Heart Failure Interventions Targeting Impaired Left Ventricles in Structural Heart Disease

被引:3
作者
Kitamura, Mitsunobu [1 ]
Schmidt, Tobias [1 ]
Kuck, Karl-Heinz [1 ]
Frerker, Christian [1 ]
机构
[1] Asklepios Klin St Georg, Dept Cardiol, Lohmuhlenstr 5, D-20099 Hamburg, Germany
关键词
Heart failure interventions; Ischaemic cardiomyopathy; Left ventricular reconstruction; Interatrial shunt device; Left ventricular outflow tract obstruction; HYPERTROPHIC CARDIOMYOPATHY; PARACHUTE(R) IMPLANTATION; RESTORATION; DEVICE;
D O I
10.1007/s11886-018-0950-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of Review Interventional techniques have been developed for a wide spectrum of mechanisms of heart failure (HF), especially in valvular heart disease and cardiomyopathies (ischaemic cardiomyopathy and hypertrophic cardiomyopathy). In this article, we review recent reports on catheter interventions to treat patients with HF. Recent Findings Direct modification using the Parachute device and the REVIVENT-TC device for patients with impaired left ventricle with large infarct scars improves geometry and haemodynamic efficiency, resulting in a reduction of HF symptoms. Interatrial shunt therapy improves symptoms and quality of life in HF patients. Uniquely, left ventricular outflow tract obstruction has also been targeted in patients with transcatheter mitral valve implantation. Summary For advanced stage HF patients with prohibitively high surgical risk, emerging transcatheter interventions make it possible to modify life-limiting symptoms. Further results on HF interventions are expected from ongoing clinical trials.
引用
收藏
页数:8
相关论文
共 34 条
[1]  
[Anonymous], PAPERS
[2]  
[Anonymous], 2016, HEART FAIL REV
[3]   Surgical anterior ventricular endocardial restoration (SAVER) in the dilated remodeled ventricle after anterior myocardial infarction [J].
Athanasuleas, CL ;
Stanley, AWH ;
Buckberg, GD ;
Dor, V ;
DiDonato, M ;
Blackstone, EH .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (05) :1199-1209
[4]  
Cooley D A, 1989, J Card Surg, V4, P200, DOI 10.1111/j.1540-8191.1989.tb00282.x
[5]  
Cooley DA, 1989, LANCET, V4, P200
[6]  
COSTA MA, 2012, AM HEART J, V12, P22
[7]   Percutaneous Ventricular Restoration Using the Parachute Device in Patients With Ischemic Heart Failure Three-Year Outcomes of the PARACHUTE First-in-Human Study [J].
Costa, Marco A. ;
Mazzaferri, Ernest L. ;
Sievert, Horst ;
Abraham, William T. .
CIRCULATION-HEART FAILURE, 2014, 7 (05) :752-758
[8]  
DelTrigo M, 2016, CIRCULATION, V387, P1290
[9]   2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC) [J].
Elliott, Perry M. ;
Anastasakis, Aris ;
Borger, Michael A. ;
Borggrefe, Martin ;
Cecchi, Franco ;
Charron, Philippe ;
Hagege, Albert Alain ;
Lafont, Antoine ;
Limongelli, Giuseppe ;
Mahrholdt, Heiko ;
McKenna, William J. ;
Mogensen, Jens ;
Nihoyannopoulos, Petros ;
Nistri, Stefano ;
Pieper, Petronella G. ;
Pieske, Burkert ;
Rapezzi, Claudio ;
Rutten, Frans H. ;
Tillmanns, Christoph ;
Watkins, Hugh .
EUROPEAN HEART JOURNAL, 2014, 35 (39) :2733-+
[10]   Experience with programmed steroid treatment with thymectomy in nonthymomatous myasthenia gravis [J].
Endo, S ;
Yamaguchi, T ;
Saito, N ;
Otani, S ;
Hasegawa, T ;
Sato, Y ;
Sohara, Y .
ANNALS OF THORACIC SURGERY, 2004, 77 (05) :1745-1750